Eam Global Investors LLC Argenx Se Transaction History

Eam Global Investors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$113.31 - $150.51 $2.27 Million - $3.01 Million	-20,025 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$115.0 - $141.58 $584,430 - $719,509	-5,082 Reduced 20.24%	20,025 $2.84 Million
Q1 2019 May 10, 2019	BUY	$98.85 - $134.59 $793,864 - $1.08 Million	8,031 Added 47.03%	25,107 $3.13 Million
Q4 2018 Feb 13, 2019	BUY	$63.81 - $109.82 $1.09 Million - $1.88 Million	17,076 New	17,076 $1.64 Million

400

30.9M

376K

489K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.3B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.